Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Apogee Therapeutics, Inc. | StockGist | StockGist

Companies
APGE
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings APGESCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Apogee Therapeutics, Inc.

Filed Mar 6, 2026

Accepted Mar 6, 2026, 12:57 PM ET

CIK 0001974640

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

11.30%

Shares Owned

6,213,827

Reporting Person

Apogee Therapeutics, Inc.

Person Type

IA

CUSIP: 03770N101

Amendment History

9 filings

SCHEDULE 13G
Original
Viewing
Mar 6, 20260001897612-26-000311
SCHEDULE 13G/A
Amendment 1
May 12, 20250000902219-25-000171
SCHEDULE 13G/A
Amendment 2
Jul 16, 20250002052113-25-002476
SCHEDULE 13G/A
Amendment 3
Aug 5, 20250000902219-25-000264
SCHEDULE 13G/A
Amendment 4
Aug 5, 20250000902219-25-000262
SCHEDULE 13G/A
Amendment 5
Aug 6, 20250000315066-25-001957
SCHEDULE 13G/A
Amendment 6
Nov 14, 20250000938206-25-000048
SCHEDULE 13G/A
Amendment 7
Feb 10, 20260000902219-26-000095
SCHEDULE 13G/A
Amendment 8
Latest
Feb 17, 20260001493215-26-000028

Key Facts

% of Class

11.30%

Shares Owned

6,213,827

Recent Filings

Apogee Therapeutics, Inc.1 weeks ago

Apogee Therapeutics, Inc.1 weeks ago

Apogee Therapeutics, Inc.1 weeks ago

Apogee Therapeutics, Inc.1 months ago

Apogee Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice